Page last updated: 2024-08-25

magnolol and Bone Loss, Osteoclastic

magnolol has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fei, WY; Huo, Q; Li, T; Qin, LJ; Zhao, PQ	1

Other Studies

1 other study(ies) available for magnolol and Bone Loss, Osteoclastic

Article	Year
Magnolol prevents ovariectomy‑induced bone loss by suppressing osteoclastogenesis via inhibition of the nuclear factor‑κB and mitogen‑activated protein kinase pathways. International journal of molecular medicine, 2019, Volume: 43, Issue:4 Topics: Actins; Animals; Biomarkers; Biphenyl Compounds; Bone Resorption; Lignans; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoclasts; Osteogenesis; Ovariectomy; Phosphorylation; RAW 264.7 Cells	2019

Article

Year

Magnolol prevents ovariectomy‑induced bone loss by suppressing osteoclastogenesis via inhibition of the nuclear factor‑κB and mitogen‑activated protein kinase pathways.

International journal of molecular medicine, 2019, Volume: 43, Issue:4

Topics: Actins; Animals; Biomarkers; Biphenyl Compounds; Bone Resorption; Lignans; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoclasts; Osteogenesis; Ovariectomy; Phosphorylation; RAW 264.7 Cells

2019